• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性痒疹患者发生睡眠障碍的风险:一项使用健康改善网络的人群水平分析。

Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network.

作者信息

Joel Marina Z, Taylor Matthew T, Cornman Hannah L, Kambala Anusha, Reddy Sriya V, Gabriel Sylvie, Kwatra Shawn G

机构信息

Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Galderma SA, Lausanne, Switzerland.

出版信息

JAAD Int. 2023 Jul 29;13:39-45. doi: 10.1016/j.jdin.2023.07.009. eCollection 2023 Dec.

DOI:10.1016/j.jdin.2023.07.009
PMID:37663166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10471919/
Abstract

BACKGROUND

Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by severely itchy and often painful bumps on the arms, legs, and trunk. It is unknown whether patients with PN have increased risk of developing sleep disorders.

OBJECTIVE

To evaluate the association of PN with sleep disorders.

METHODS

This retrospective, population-level, matched-cohort study was conducted using The Health Improvement Network. The study included 4193 patients with newly diagnosed PN and 4193 age, sex, and race/ethnicity-matched controls. A Cox regression model was used to assess the development of sleep disorders, including insomnia, sleep apnea, and restless legs syndrome, in patients with PN compared with control patients.

RESULTS

Compared with controls, PN was associated with insomnia (adjusted hazard ratio [aHR] = 1.77; 95% CI = 1.48-2.12) and overall sleep disorder (aHR = 1.72; 95% CI = 1.46-2.02), but not with sleep apnea (aHR = 1.51; 95% CI = 0.93-2.44) or restless legs syndrome (aHR = 1.54; 95% CI = 0.92-2.57).

LIMITATIONS

As a retrospective cohort study, our analysis is subject to potential confounders not already included.

CONCLUSIONS

PN was associated with subsequent development of insomnia. Thus, clinicians should consider insomnia among patients with PN and develop strategies for treatment and prevention.

摘要

背景

结节性痒疹(PN)是一种慢性炎症性皮肤病,其特征是手臂、腿部和躯干上出现严重瘙痒且常伴有疼痛的肿块。目前尚不清楚PN患者患睡眠障碍的风险是否增加。

目的

评估PN与睡眠障碍之间的关联。

方法

本回顾性、基于人群的匹配队列研究使用了健康改善网络。该研究纳入了4193例新诊断为PN的患者以及4193例年龄、性别和种族/民族匹配的对照。采用Cox回归模型评估PN患者与对照患者相比发生睡眠障碍(包括失眠、睡眠呼吸暂停和不宁腿综合征)的情况。

结果

与对照组相比,PN与失眠(调整后风险比[aHR]=1.77;95%置信区间[CI]=1.48-2.12)和总体睡眠障碍(aHR=1.72;95%CI=1.46-2.02)相关,但与睡眠呼吸暂停(aHR=1.51;95%CI=0.93-2.44)或不宁腿综合征(aHR=1.54;95%CI=0.92-2.57)无关。

局限性

作为一项回顾性队列研究,我们的分析可能受到未纳入的潜在混杂因素的影响。

结论

PN与随后发生的失眠相关。因此,临床医生应考虑PN患者中的失眠情况,并制定治疗和预防策略。

相似文献

1
Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network.结节性痒疹患者发生睡眠障碍的风险:一项使用健康改善网络的人群水平分析。
JAAD Int. 2023 Jul 29;13:39-45. doi: 10.1016/j.jdin.2023.07.009. eCollection 2023 Dec.
2
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.结节性痒疹:发病机制的新见解和新疗法。
Br J Dermatol. 2024 May 17;190(6):798-810. doi: 10.1093/bjd/ljae052.
3
The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.睡眠障碍数字评定量表:结节性痒疹的内容效度、心理测量学验证及有意义的患者内变化
Dermatol Ther (Heidelb). 2023 Jul;13(7):1587-1602. doi: 10.1007/s13555-023-00962-8. Epub 2023 Jun 17.
4
Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.英国结节性痒疹的患病率、发病率和治疗模式:一项回顾性数据库分析。
Br J Dermatol. 2024 Sep 18;191(4):548-555. doi: 10.1093/bjd/ljae207.
5
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.尼莫利珠单抗治疗结节性痒疹的疗效:对瘙痒和睡眠障碍的起效时间。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1820-1825. doi: 10.1111/jdv.18377. Epub 2022 Jul 4.
6
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.结节性痒疹的病理生理学、诊断和药物治疗。
Expert Rev Clin Pharmacol. 2021 Jan;14(1):67-77. doi: 10.1080/17512433.2021.1852080. Epub 2020 Dec 11.
7
Sleep apnea in patients reporting insomnia or restless legs symptoms.报告有失眠或不宁腿症状患者的睡眠呼吸暂停。
Acta Neurol Scand. 2016 Jan;133(1):61-7. doi: 10.1111/ane.12439. Epub 2015 May 14.
8
Ethnic differences and comorbidities of 909 prurigo nodularis patients.909 例结节性痒疹患者的种族差异和合并症。
J Am Acad Dermatol. 2018 Oct;79(4):714-719.e3. doi: 10.1016/j.jaad.2018.04.047. Epub 2018 May 4.
9
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.人源单克隆抑瘤素M受体β抗体维卡瑞单抗治疗中度至重度结节性痒疹的疗效和安全性:一项随机、双盲、安慰剂对照的2a期研究
EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar.
10
Serotonin and interleukin-6: Association with pruritus severity, sleep quality and depression severity in Prurigo Nodularis.血清素和白细胞介素-6:与结节性痒疹的瘙痒严重程度、睡眠质量和抑郁严重程度的相关性。
Asian J Psychiatr. 2015 Oct;17:24-8. doi: 10.1016/j.ajp.2015.07.010. Epub 2015 Jul 26.

引用本文的文献

1
Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis.结节性痒疹患者睡眠日记改编版的内容效度和心理测量学验证
Dermatol Ther (Heidelb). 2025 Jun;15(6):1405-1426. doi: 10.1007/s13555-025-01406-1. Epub 2025 Apr 23.
2
Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.结节性痒疹皮肤-肝脏轴失调:一项综合基因组、转录组和基于人群的分析。
Genes (Basel). 2024 Jan 23;15(2):146. doi: 10.3390/genes15020146.

本文引用的文献

1
Prurigo Nodularis.结节性痒疹
JAMA Dermatol. 2022 Mar 1;158(3):336. doi: 10.1001/jamadermatol.2021.5307.
2
Health-related quality of life and economic burden of prurigo nodularis.结节性痒疹的健康相关生活质量和经济负担
J Am Acad Dermatol. 2022 Mar;86(3):573-580. doi: 10.1016/j.jaad.2021.05.036. Epub 2021 May 28.
3
Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.结节性痒疹患者瘙痒对睡眠障碍的影响
Acta Derm Venereol. 2021 Mar 31;101(3):adv00424. doi: 10.2340/00015555-3778.
4
Prurigo nodularis: Epidemiology and clinical features.结节性痒疹:流行病学和临床特征。
J Am Acad Dermatol. 2020 Dec;83(6):1559-1565. doi: 10.1016/j.jaad.2020.04.183. Epub 2020 May 23.
5
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.度普利尤单抗可改善慢性结节性痒疹成年患者的临床表现、症状和生活质量。
J Am Acad Dermatol. 2020 Jul;83(1):39-45. doi: 10.1016/j.jaad.2020.03.049. Epub 2020 Mar 27.
6
Breaking the Itch-Scratch Cycle in Prurigo Nodularis.打破结节性痒疹的瘙痒-搔抓循环
N Engl J Med. 2020 Feb 20;382(8):757-758. doi: 10.1056/NEJMe1916733.
7
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.尼莫利珠单抗治疗中重度结节性痒疹的试验。
N Engl J Med. 2020 Feb 20;382(8):706-716. doi: 10.1056/NEJMoa1908316.
8
Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis.结节性痒疹患者的诊断检查与评估
Medicines (Basel). 2019 Sep 26;6(4):97. doi: 10.3390/medicines6040097.
9
Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center.HIV 相关皮肤状况的种族差异:城市三级保健中心 4679 例患者的横断面研究。
J Am Acad Dermatol. 2020 May;82(5):1117-1123. doi: 10.1016/j.jaad.2019.08.072. Epub 2019 Sep 6.
10
Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases.结节性痒疹的真实世界患病率及相关疾病负担
J Invest Dermatol. 2020 Feb;140(2):480-483.e4. doi: 10.1016/j.jid.2019.07.697. Epub 2019 Aug 15.